Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan

Sponsor
GlaxoSmithKline (Industry)
Overall Status
Completed
CT.gov ID
NCT01479491
Collaborator
(none)
54

Study Details

Study Description

Brief Summary

This study aims to analyse baseline data on IS in order to monitor the possibility of increased risk of IS in children aged <12 months after introduction of the Rotarix vaccination in Japan.

Condition or Disease Intervention/Treatment Phase
  • Other: Data collection

Study Design

Study Type:
Observational
Actual Enrollment :
54 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Observational Database Study on the Incidence of Intussusception in Children Aged < 12 Months in Japan
Study Start Date :
Nov 1, 2011
Actual Primary Completion Date :
Nov 1, 2011
Actual Study Completion Date :
Nov 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Case Group

Children aged < 12 months presenting with IS and covered by the Japan Medical Data Centre Company Limited (JMDC), Tokyo referred to as the JMDC Medical Data Bank (JMDC-MDB).

Other: Data collection
Data source will be the Japan Medical Data Centre Company Limited (JMDC) - JMDC Medical Data Bank (JMDC-MDB) database. Aggregated data (age in months and years and gender) for all subjects recorded in the database and subject-level data for IS cases will be extracted from the database. This database will be reviewed to extract data for the period between January 2005 and April 2011. Cases of IS will be identified using the International Classification of Diseases-10 (ICD-10) diagnostic codes, examination codes and procedural codes.

Outcome Measures

Primary Outcome Measures

  1. Occurrence of IS in subjects aged < 12 months [Between January 2005 and April 2011 (6 years)]

  2. Occurrence of age-specific and gender-specific incidence of IS among subjects aged < 12 months in Japan [Between January 2005 and April 2011 (6 years)]

Secondary Outcome Measures

  1. Number of IS cases hospitalized more than once among subjects aged < 12 months. [Between January 2005 and April 2011 (6 years)]

  2. Occurrence of IS cases by calendar months and year among subjects aged < 12 months [Between January 2005 and April 2011 (6 years)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 12 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A male or female infant aged < 12 months at the time of IS diagnosis and affiliated to the JMDC-MDB database.

  • An IS case should be identified as per the ICD-10 diagnostic code-K56.1 (any-field listed), examination codes, and procedural codes.

Exclusion Criteria:

Not applicable

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • GlaxoSmithKline

Investigators

  • Study Director: GSK Clinical Trials, GlaxoSmithKline

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01479491
Other Study ID Numbers:
  • 116259
First Posted:
Nov 24, 2011
Last Update Posted:
Oct 22, 2012
Last Verified:
Oct 1, 2012
Keywords provided by GlaxoSmithKline
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 22, 2012